Cuban Program to Treat Hemophiliac Patients Wins Award
- Submitted by: manso
- 09 / 21 / 2011
2011.09.20 - 10:22:15 / radiorebelde.icrt.cu.HAVANA, Cuba.- The Novo Nordisk Foundation for Hemophilia, which support in developing nations actions aimed at improving the treatment and knowledge of this disease, has granted Cuba the Prize for the Project of 2010.
The prize of this non-governmental organization based in Switzerland was given to the Institute of Hematology and Immunology (IHI), which leads the National Program for the Comprehensive Attention to Hemophiliac Patients, and to the provinces of Pinar del Rio and Villa Clara, the Infomed Web site reported on Monday.
This took place at the 22nd International Congress of the Latin American Group of Haemosthasia and Thrombosis, recently held in Uruguay, the Evaluation Council of which selected the Caribbean island among the 41 projects from 29 countries presented on the basis of the optimization of the attention to patients.
For almost three years, the IHI and the aforementioned Cuban territories managed to consolidate haemosthasia labs, as well as the training of the multidisciplinary teams taking care of patients.
Also excelling is the carrying out of workshops for the health staff, patients and relatives, aimed at increasing knowledge about the disease, its complications and ways to treat it and prevent it.
During the meeting, Cuba presented its achievements in this field, in the presence of representatives from Venezuela, Honduras, Mexico, Costa Rica, Panama, El Salvador, the Dominican Republic, Peru and Brazil, among other nations.
The Novo Nordisk Foundation for Hemophilia was created in 2005 in view of the need of improving attention to this disease in the world, since in many nations it’s not a health priority and there are many patients without a diagnose or treated inappropriately.
Dr. Jose Manuel Ballester, president of the Cuban Society of Hematology and director of the IHI, explained that Cuba guarantees comprehensive medical attention to the over 400 hemophiliac patients on the island, with medicaments produced in the country or imported. (ACN)